Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Atara Biotherapeutics, Inc. (ATRA) had Return on Tangible Equity of -69.02% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$98.15M |
|
$38.01M |
|
$20.44M |
|
$77.71M |
|
$59.35M |
|
$38.80M |
|
$-0.79M |
|
$38.01M |
|
$38.01M |
|
$38.01M |
|
$38.01M |
|
$38.01M |
|
$38.01M |
|
$38.80M |
|
$40.86M |
|
10.76M |
|
10.85M |
|
$3.53 |
|
$3.50 |
|
| Balance Sheet Financials | |
$27.18M |
|
$0.28M |
|
$34.86M |
|
$62.04M |
|
$47.89M |
|
-- |
|
$69.22M |
|
$117.11M |
|
$-55.07M |
|
$-55.07M |
|
$-55.07M |
|
5.92M |
|
| Cash Flow Statement Financials | |
$-28.14M |
|
$17.20M |
|
$-0.25M |
|
$25.18M |
|
$13.99M |
|
$-11.19M |
|
$4.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
79.18% |
|
39.53% |
|
39.53% |
|
-- |
|
38.73% |
|
38.73% |
|
$-28.14M |
|
-- |
|
-- |
|
-- |
|
1.58 |
|
-- |
|
11.06 |
|
8.14 |
|
-69.02% |
|
|
Return on Tangible Equity |
-69.02% |
61.27% |
|
-69.02% |
|
$-9.30 |
|
$-2.59 |
|
$-2.59 |
|